Abstract:Background. Oxygen free radicals (OFRs), platelet activating factor (PAF), cell adhesion molecules, and transmigration of polymorphonuclear leukocytes through the gut barrier are probably all essential in the development of gut barrier dysfunction following intestinal ischemia and reperfusion (I/R). Pretreatment and early treatment of I/R with the OFRs-scavenger (NAC), the PAF inhibitor lexipafant, and monoclonal antibodies against the adhesion molecule PECAM-1 (anti-PECAM-1-Mab) have been reported to be effective in the prevention or recovery of gut barrier dysfunction and result in a decrease in cytokine levels. Less is known about the effect of treatment inserted during the late stage of I/R. The objective of this study was to evaluate the potential therapeutic value of single or combination therapy with NAC, lexipafant, and anti-PECAM-1-MAb administered late during intestinal I/R in the rat.Methods. NAC, lexipafant, and anti-PECAM-1-MAb were administrated, alone or in combination, after 3 h of reperfusion following 40 min of superior mesenteric arterial ischemia in the rat. Intestinal endothelial and epithelial barrier permeability, myeloperoxidase (MPO) activity, interleukin-1beta (IL-1beta), and protease inhibitor levels were evaluated after 12 h of reperfusion.Results. Intestinal endothelial and epithelial permeability significantly increased in rats with I/R and saline treatment. Proteolytic activity in plasma was indicated, by low levels of the three measured plasma protease inhibitors. Intestinal mucosal MPO content increased significantly. These changes were, to different degrees, reduced by late inserted treatment with NAC, lexipafant, or anti-PECAM-1-MAb. Alterations in systemic levels of IL-1beta paralleled the changes found in gut barrier permeability and leukocyte trapping. Systemic antithrombin III levels and increased barrier permeability in remote organs were partly restored, especially by multimodal therapy.Conclusion. Treatment with NAC, lexipafant, and/or monoclonal antibodies against PECAM-1, inserted at a later stage of I/R, reduced the severity of I/R-associated intestinal dysfunction and decreased the systemic concentrations of IL-1beta, local leukocyte recruitment (MPO), and partly restored plasma protease inhibitor levels. (C) 2002 Elsevier Science (USA).

Treatment with Lexipafant Ameliorates the Severity of Pancreatic Microvascular Endothelial Barrier Dysfunction in Rats with Acute Hemorrhagic Pancreatitis

Pancreatitis-associated Pulmonary Injury: Effects of Lexipafant, a Platelet-Activating Factor Antagonist

Effect of a Platelet-Activating Factor Antagonist on Pancreatitis-Associated Gut Barrier Dysfunction in Rats.

Beneficial Effects of Lexipafant, A Paf Antagonist on Gut Barrier Dysfunction Caused by Intestinal Ischemia and Reperfusion in Rats

Effect of Baicalin and Octreotide on the Expression Levels of P‐selectin Protein in Multiple Organs of Rats with Severe Acute Pancreatitis

Effect of Baicalin on Inflammatory Mediator Levels and Microcirculation Disturbance in Rats with Severe Acute Pancreatitis

Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.

Lexipafant - a glimmer of hope for pancreatitis

Lexipafant for acute pancreatitis: a systematic review

Early Peritoneal Lavage with Ulinastatin Improves Outcome and Enhances Multi-Organ Protection in a Model of Severe Acute Pancreatitis.

Low-Methoxyl Lemon Pectin Attenuates Inflammatory Responses and Improves Intestinal Barrier Integrity in Caerulein-Induced Experimental Acute Pancreatitis

Peritoneal Lavage With Ulinastatin Reduced The Expression Levels Of P-Selectin Protein In Severe Acute Pancreatitis Rats

Therapeutic Effect of Ultrasound Interventional Perirenal Catheter-Assisted Early Peripancreatic Lavage of Protease Inhibitor on Severe Acute Pancreatitis in Miniature Pigs

Effective Treatment of Gut Barrier Dysfunction Using an Antioxidant, a PAF Inhibitor, and Monoclonal Antibodies Against the Adhesion Molecule PECAM-1.

Experimental study of the effect of platelet-activating factor acetylhydrolase on severe acute pancreatitis

Influence of Platelet Activating Factor on Expression of Adhesion Molecules in Experimental Pancreatitis

Antioxidant and Calcium Channel Blockers Counteract Endothelial Barrier Injury Induced by Acute Pancreatitis in Rats.

Cartilage Oligomeric Matrix Protein-Angiopoietin-1 Has a Protective Effect of Vascular Endothelial Barrier in Rat with Acute Necrotizing Pancreatitis

Effect of platelet-activating factor acetylhydrolase on severe acute pancreatitis-induced lung injury in rats

Expression of platelet endothelial cell adhesion molecule-1 between pancreatic microcirculation and peripheral circulation in rats with acute edematous pancreatitis.

Angiotensin-(1-7) Treatment Restores Pancreatic Microcirculation Profiles: A New Story in Acute Pancreatitis